Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Health Care
  • News

Minister Of Health And Wellness In Jamaica Dr. Chris Tufton Tweets, ‘We have our first confirmed case of Monkeypox. The patient is a male who recently travelled from the United Kingdom.’

By Michael Horton
July 6, 4:57 PM
https://twitter.com/christufton/status/1544785970129674240

AEMD

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

Adverum Biotechnologies Completes IND Amendment And Prepares To Initiate The Phase 2 LUNA Trial Of ADVM-022 In Wet AMD

By Benzinga Newsdesk
July 6, 4:10 PM
- Cash runway extended into 2025 due to corporate restructuring to prioritize the clinical development of ADVM-022 and provide additional resources beyond anticipated one-year topline results of the Phase 2 LUNA trial -

ADVM

Read More
2 minute read
  • Biotech
  • General

Calithera Biosciences Announces First Patient Enrolled In Phase 2 Clinical Trial Of Sapanisertib In Relapsed/Refractory NRF2 (NFE2L2)-Mutated Squamous Non-Small Cell Lung Cancer

By Bill Haddad
July 6, 4:01 PM
Calithera Biosciences, Inc. (NASDAQ:CALA), a clinical-stage, precision-oncology biopharmaceutical company, today announced that it has enrolled the first patient in a phase 2 clinical trial of sapanisertib (CB-228) in

CALA

Read More
2 minute read
  • General

2022’s Best-Performing Sector Just Hit Bear Market Territory

By Aaron Bry
July 6, 3:40 PM
Slow Start: 2022 has been a brutal year for stocks. In fact, the first six months of the year were the worst first six months for the stock market in more than 50 years, according to NPR. 

BTU

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Government
  • Health Care
  • News

Drugmakers, Health Authorities Discarding Several Million COVID-19 Vaccine Doses: Report

By Vandana Singh
July 6, 3:12 PM
Wall Street Journal reported that governments, drugmakers, and vaccination sites are discarding several unused COVID-19 vaccine doses amid declining…

AZN

Read More
1 minute read
  • General
  • M&A
  • News
  • Small Cap

Vista Outdoor Acquires Fox Racing: Read What’s The Advantage

By Shivani Kumaresan
July 6, 3:09 PM
Vista Outdoor Inc (NYSE:VSTO) has agreed to acquire California-based Fox Racing, a performance motocross, mountain bike, and lifestyle gear provider,…

VSTO

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Touchlight Inks Patent License Agreement With Pfizer

By Vandana Singh
July 6, 3:08 PM
Touchlight, a biotechnology company pioneering enzymatic DNA production, announced a non-exclusive patent license agreement with Pfizer Inc (NYSE:PFE). The pharma giant has…

PFE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

AstraZeneca’s COVID-19 Treatment Allowed In China’s Southern City: Reuters

By Vandana Singh
July 6, 3:06 PM
AstraZeneca Plc’s (NASDAQ:AZN) COVID-19 antibody cocktail has been cleared for use in a medical tourism zone in China’s southern…

AZN

Read More
2 minute read
  • Education
  • General
  • Topics

Do You Think You May Get Laid Off? Here Are 5 Tips On How To Keep Your Job During A Recession

By AJ Fabino
July 6, 2:11 PM
The Federal Reserve's conclusion that the job market is tight is supported by the most recent figures on unemployment claims. However, layoffs are getting worse, led by the crypto and tech industries.

COIN

Read More
1 minute read
  • Biotech
  • General

Erytech Pharma Granted Australia Patent Titled ‘Arginine Deiminase Encapsulated Inside Erythrocytes And Their Use In Treating Cancer’

By Bill Haddad
July 6, 2:08 PM
https://twitter.com/US_Patent_Plays/status/1544744441755353091

ERYP

Posts pagination

Previous 1 … 2,356 2,357 2,358 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service